NCT01669122View on ClinicalTrials.gov

Pharmacokinetic Study of 4 mg Nicotine Lozenge.

PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Smoking Cessation

Interventions

DRUG

nicotine

4 mg nicotine lozenge experimental

Trial Locations (1)

380 061

Lambda Therapeutic Research Ltd, Ahmedabad

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01669122 - Pharmacokinetic Study of 4 mg Nicotine Lozenge. | Biotech Hunter | Biotech Hunter